Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-α

被引：28

作者：

Akashi-Takamura, Sachiko

Furuta, Takahisa

Takahashi, Koichiro

Tanimura, Natsuko

Kusumoto, Yutaka

Kobayashi, Toshihiko

Saitoh, Shin-ichiroh

Adachi, Yoshiyuki

Doi, Takahiro

Miyake, Kensuke

机构：

[1] Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan

[2] Japan Sci & Technol, Core Res Engn Sci & Technol, Tokyo, Japan

[3] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Tokyo, Japan

[4] RIKEN, Tsukuba Inst, Bioresource Ctr, Subteam BioSignal Integrat,Technol & dev Team Bio, Ibaraki, Japan

来源：

JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 07期

关键词：

D O I：

10.4049/jimmunol.176.7.4244

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

LPS is recognized by a heterodimer consisting of TLR4 and its coreceptor MD-2. LPS signal causes excessive inflammation and tissue damage. In this study, we show that a mAb to TLR4/MD-2 protected mice from acute lethal hepatitis caused by LPS/D-galactosamine. The protective effect of the mAb was not due to inhibition of LPS response, because serum TNF-alpha, which was induced by LPS and caused lethal hepatitis, was 10 times up-regulated by the mAb pretreatment. Moreover, this mAb induced antiapoptotic genes in liver in a TLR4/MD-2-dependent manner. These results demonstrated that an agonistic mAb to TLR4/ MD-2 protected mice from LPS/D-galactosamine-induced acute lethal hepatitis by delivering a protective signal activating NF-kappa B through TLR4/MD-2.

引用

收藏

页码：4244 / 4251

页数：8

相关论文

共 34 条

[21] PEF-BOS, A POWERFUL MAMMALIAN EXPRESSION VECTOR [J].

MIZUSHIMA, S ;

NAGATA, S .

NUCLEIC ACIDS RESEARCH, 1990, 18 (17) :5322-5322

[22] Essential role of MD-2 in LPS responsiveness and TLR4 distribution [J].

Nagai, Y ;

Akashi, S ;

Nagafuku, M ;

Ogata, M ;

Iwakura, Y ;

Akira, S ;

Kitamura, T ;

Kosugi, A ;

Kimoto, M ;

Miyake, K .

NATURE IMMUNOLOGY, 2002, 3 (07) :667-672

[23]

NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D

[24] Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:: Mutations in Tlr4 gene [J].

Poltorak, A ;

He, XL ;

Smirnova, I ;

Liu, MY ;

Van Huffel, C ;

Du, X ;

Birdwell, D ;

Alejos, E ;

Silva, M ;

Galanos, C ;

Freudenberg, M ;

Ricciardi-Castagnoli, P ;

Layton, B ;

Beutler, B .

SCIENCE, 1998, 282 (5396) :2085-2088

[25] Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4) [J].

Qureshi, ST ;

Larivière, L ;

Leveque, G ;

Clermont, S ;

Moore, KJ ;

Gros, P ;

Malo, D .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) :615-625

[26] Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization [J].

Saitoh, S ;

Akashi, S ;

Yamada, T ;

Tanimura, N ;

Kobayashi, M ;

Konno, K ;

Matsumoto, F ;

Fukase, K ;

Kusumoto, S ;

Nagai, Y ;

Kusumoto, Y ;

Kosugi, A ;

Miyake, K .

INTERNATIONAL IMMUNOLOGY, 2004, 16 (07) :961-969

[27] Molecular genetic analysis of an endotoxin nonresponder mutant cell Line: A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling [J].

Schromm, AB ;

Lien, E ;

Henneke, P ;

Chow, JC ;

Yoshimura, A ;

Heine, H ;

Latz, E ;

Monks, BG ;

Schwartz, DA ;

Miyake, K ;

Golenbock, DT .

JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (01) :79-88

[28] STRUCTURE AND FUNCTION OF LIPOPOLYSACCHARIDE BINDING-PROTEIN [J].

SCHUMANN, RR ;

LEONG, SR ;

FLAGGS, GW ;

GRAY, PW ;

WRIGHT, SD ;

MATHISON, JC ;

TOBIAS, PS ;

ULEVITCH, RJ .

SCIENCE, 1990, 249 (4975) :1429-1431

[29] MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 [J].

Shimazu, R ;

Akashi, S ;

Ogata, H ;

Nagai, Y ;

Fukudome, K ;

Miyake, K ;

Kimoto, M .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1777-1782

[30] Toll-like receptors [J].

Takeda, K ;

Kaisho, T ;

Akira, S .

ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :335-376

← 1 2 3 4 →